Terug
Dagbereik
€ 14,88
€ 16,04
52-Weeksbereik
€ 3,50
€ 25,77
Volume
1.306.355
50D / 200D Gem.
€ 19,78
/
€ 11,73
Vorige Slotkoers
€ 14,72
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -26,5 | 0,3 |
| P/B | 4,4 | 3,0 |
| ROE % | -16,9 | 3,7 |
| Net Margin % | -31,2 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 31,75
+102.1%
Low: € 22,00
High: € 37,00
Forward WPA
-€ 1,52
Omzet Sch.
56,75M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 1,60
-€ 4,15 – -€ 0,19
|
170,51M | 1 |
| FY2029 |
-€ 2,13
-€ 5,51 – -€ 0,25
|
118,37M | 1 |
| FY2028 |
-€ 2,26
-€ 2,90 – -€ 1,47
|
38,17M | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-17 | -€ 0,35 | -€ 0,54 | -53,6% |
| 2025-11-06 | -€ 0,37 | -€ 0,33 | +9,9% |
| 2025-08-07 | -€ 0,38 | -€ 0,15 | +60,2% |
| 2025-05-08 | € 0,00 | € 0,57 | +21690,9% |
| 2025-03-20 | € 0,02 | € 0,23 | +1379,1% |
| 2024-11-07 | -€ 0,49 | -€ 0,29 | +40,8% |
| 2024-08-08 | -€ 0,54 | -€ 0,43 | +20,4% |
| 2024-05-09 | -€ 0,57 | -€ 0,53 | +7,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,17 — conservative balance sheet
Negative free cash flow of -27,50M
PEG of 0,64 suggests growth is underpriced
Capital efficient — spends only 3,80% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)63,54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-16,94%
ROIC-14,93%
Net Margin-31,23%
Op. Margin-43,83%
Veiligheid
Debt / Equity
0,17
Current Ratio6,12
Interest Coverage0,00
Waardering
P/E Ratio
-26,49
Forward P/EN/A
P/B Ratio4,39
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 63,54% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 123,67M | Net Income (TTM) | -38,63M |
| ROE | -16,94% | ROA | -8,61% |
| Gross Margin | 93,24% | Operating Margin | -43,83% |
| Net Margin | -31,23% | Free Cash Flow (TTM) | -27,50M |
| ROIC | -14,93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 6,12 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -26,49 | Forward P/E | N/A |
| P/B Ratio | 4,39 | P/S Ratio | 8,27 |
| PEG Ratio | 0,64 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 49,37 |
| Forward P/S | 18,03 | Fwd Earnings Yield | N/A |
| FCF Yield | -2,69% | ||
| Market Cap | 1,02B | Enterprise Value | 932,39M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 123,67M | 75,62M | 0,0 | 0,0 | 0,0 |
| Net Income | -38,63M | -72,70M | -135,35M | -108,50M | -73,96M |
| EPS (Diluted) | -0,46 | -0,98 | -2,63 | -2,30 | -1,59 |
| Gross Profit | 115,32M | 67,50M | -6,22M | 0,0 | 0,0 |
| Operating Income | -54,21M | -81,11M | -143,31M | -112,38M | -72,88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 448,66M | 438,73M | 303,76M | 342,39M | 366,33M |
| Total Liabilities | 215,60M | 215,80M | 124,51M | 70,98M | 18,81M |
| Shareholders' Equity | 233,06M | 222,94M | 179,25M | 271,41M | 347,52M |
| Total Debt | 39,19M | 42,72M | 46,04M | 47,00M | 0,0 |
| Cash & Equivalents | 129,88M | 224,25M | 128,10M | 54,91M | 346,07M |
| Current Assets | 393,19M | 377,44M | 236,21M | 275,89M | 348,67M |
| Current Liabilities | 64,21M | 156,95M | 46,59M | 25,57M | 16,64M |